CA1118328A - Device for detecting deoxyribonuclease production - Google Patents
Device for detecting deoxyribonuclease productionInfo
- Publication number
- CA1118328A CA1118328A CA000325042A CA325042A CA1118328A CA 1118328 A CA1118328 A CA 1118328A CA 000325042 A CA000325042 A CA 000325042A CA 325042 A CA325042 A CA 325042A CA 1118328 A CA1118328 A CA 1118328A
- Authority
- CA
- Canada
- Prior art keywords
- matrix
- production
- deoxyribonuclease
- test device
- methyl green
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000016911 Deoxyribonucleases Human genes 0.000 title claims abstract description 41
- 108010053770 Deoxyribonucleases Proteins 0.000 title claims abstract description 41
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 18
- 238000012360 testing method Methods 0.000 claims abstract description 30
- 108020004414 DNA Proteins 0.000 claims abstract description 22
- 102000053602 DNA Human genes 0.000 claims abstract description 22
- 239000011159 matrix material Substances 0.000 claims abstract description 21
- DWCZIOOZPIDHAB-UHFFFAOYSA-L methyl green Chemical compound [Cl-].[Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)[N+](C)(C)C)=C1C=CC(=[N+](C)C)C=C1 DWCZIOOZPIDHAB-UHFFFAOYSA-L 0.000 claims abstract description 18
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 16
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 12
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 10
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 10
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 10
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 10
- 230000002906 microbiologic effect Effects 0.000 claims abstract description 9
- 229920003169 water-soluble polymer Polymers 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 6
- 239000003112 inhibitor Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 238000005470 impregnation Methods 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 4
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 claims description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 2
- 229930182566 Gentamicin Natural products 0.000 claims description 2
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims description 2
- 229960003942 amphotericin b Drugs 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- IQWHCHZFYPIVRV-UHFFFAOYSA-I pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatome Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].CCC(C)CCCCC(=O)NC(CCNCS([O-])(=O)=O)C(=O)NC(C(C)O)C(=O)NC(CCNCS([O-])(=O)=O)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCNCS([O-])(=O)=O)NC(=O)C(CCNCS([O-])(=O)=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCNCS([O-])(=O)=O)NC1=O IQWHCHZFYPIVRV-UHFFFAOYSA-I 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 17
- 229940068984 polyvinyl alcohol Drugs 0.000 description 13
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 13
- 244000005700 microbiome Species 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 229940105329 carboxymethylcellulose Drugs 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 239000005547 deoxyribonucleotide Substances 0.000 description 5
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 241000194017 Streptococcus Species 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 230000002745 absorbent Effects 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 3
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229940093496 esculin Drugs 0.000 description 3
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 3
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229910001868 water Inorganic materials 0.000 description 3
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 2
- 230000007064 DNA hydrolysis Effects 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000013000 chemical inhibitor Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 2
- 229940120668 salicin Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RQFCJASXJCIDSX-UHFFFAOYSA-N 14C-Guanosin-5'-monophosphat Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(O)=O)C(O)C1O RQFCJASXJCIDSX-UHFFFAOYSA-N 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- AEOBEOJCBAYXBA-UHFFFAOYSA-N A2P5P Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1OP(O)(O)=O AEOBEOJCBAYXBA-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 206010061372 Streptococcal infection Diseases 0.000 description 1
- 241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
- 229950006790 adenosine phosphate Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- -1 fleeces Substances 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 239000007793 ph indicator Substances 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 201000006509 pleuropneumonia Diseases 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/922—Ribonucleases (RNAses); Deoxyribonucleases (DNAses)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
ABSTRACT
DEVICE FOR DETECTING DEOXYRIBONUCLEASE PRODUCTION
A test device, process for making the device and method of determining the production of deoxyribonuclease in a microbiological sample are disclosed. More parti-cularly, a test device is provided for determination of deoxyribonuclease production in a microbiological sample, which device comprises a carrier matrix and, incorporated therewith, deoxyribonucleic acid, methyl green and a water-soluble polymer selected from polyvinyl alcohol and carboxymethylcellulose.
DEVICE FOR DETECTING DEOXYRIBONUCLEASE PRODUCTION
A test device, process for making the device and method of determining the production of deoxyribonuclease in a microbiological sample are disclosed. More parti-cularly, a test device is provided for determination of deoxyribonuclease production in a microbiological sample, which device comprises a carrier matrix and, incorporated therewith, deoxyribonucleic acid, methyl green and a water-soluble polymer selected from polyvinyl alcohol and carboxymethylcellulose.
Description
Docket No. 11594 DEVICE FOR DETECTING DEOXYRIBONUCLEASE PRODUCTION
The present invention relates generally to the field of microbiological test devices and, more particularly, to - 5 a test device, process for making the device and method of determining the production of deoxyribonuc]ease in a microbiological sample.
BACKGROUND OF THE INVENTION
; The ability of an organism to break down deoxyribo-nucleic acid (DNA) by means of a deoxyribonuclease (DNAase) has been used clinically to differentiate between groups of microorganisms [Rothberg, N.W. et aZ. J. Baot., 90:294-295 fl965~; BZa~evic, D.J. et aZ. Am. J. CZin. PathoZ. 51: 277-279 fl9ff9); Mart~n, W.J. et aZ. Canad. J. MiorobioZ., 13:
15 616-618 (1967~], to aid in determining the potential pathogenicity of staphylococci lWeekman, B.G. et aZ. J.
Baot., 73:7~7-753, (1957)], and to determine the immuno-logical response to group A streptococcal infections [Wannamaker, L.~., In Vhr, J.W., Ed. The Strepto¢ocous, Rheumati¢ Fever, and GZomeruZonephritis, WiZZiam~ B ~iZkins, BaZt~more (1965)].
DNA is a polynucleotide that is composed of a chain of deoxyribonucleotide units. Deoxyribonucleotides are , phosphoric acid esters of nucleosides (a pyrimidine or purine base attached to deoxyribose). The phosphoric ~L
:
,. . . .
, .
., ; .
1~L18328 acid is attached to the deoxyribose ring at either the 3 or 5' position. Examples of deoxyribonucleotides are adenosine-5'-monophosphate (5'-AMP) and guanosine-S'-mono-phosphate (5'-GMP~.
DNAase is an extracellular enzyme that hydrolyzes DNA
to yield oligonucleotides (chains of several deoxyribo-nucleotides). The DNAase of Serratia mar~e6cens yields di-, tri-, and tetranucleotides [NestZe, M. et aZ. J.
BioZ. Chem. 244:5219-5225 (1969) 3. The DNAase of Group A
streptococci produces predominantly products having a chain length of 3 to 10 deoxyribonucleotide units, but also produces mononucleotides [Wannamaker, supra].
DNA has physical and chemical properties different from those of oligonucleotides or mononucleotides, and advantage has been taken of these differences to detect the hydrolysis of DNA by DNAase. Not all of the many methods proposed to determine hydrolysis of DNA are applicable in the clinical laboratory.
An improved medium for detecting DNAase production has been developed [Smith, P.B. et aZ. AppZ. M~crobioZ.
18:991-993 fl969)]. This method utilized a DNAase test medium to which is added methyl green. Methyl green com-bines with DNA to form a green complex at pH 7.5. If the DNA is hydrolyzed, the methyl green is released and be-comes a colorless compound [Kurnick, N.B. et aZ. Arch.
Biochem. 29;41-53 fl950)]. Therefore, the uninoculated medium with DNA is green, if an organism produces DNAase a colorless zone will be seen around the colonies. Gram-positive organisms grow well on this medium.
; 30 Most of the bacterial DNAases studied have been found to require the presence of divalent cations for their activity [Wannamaker, supra]. Media containing peptones will usually contain th~se cations. The pH optima have also been investigated and have been found to range from 5.5 to 8. 5 [Wannamaker, supra; NestZe~ M. et aZ. J. BioZ.
Chem. 244:5213-5218 rl969)]. For clinical purposes, media with a pH of 7.2 have been found to be satisfactory.
.
In another line of investigation, methods have recently been devised in which the standard nutrient medium plate or tube is replaced by nutrient impregnated pads Such devices may comprise a bibulous material such as paper into which the nutrient medium is incorporated in a dried state. These devices are usually employed as test devices by reconstituting the dry media with a sterile fluid, streaking or otherwise contacting the surface of the device with the fluid specimen to be tested, incubating the same under standardized conditions and observing the growth of microorganism locations on the surface. Exemplary of such devices are those disclosed in U.S. Patents Nos.
3,699,003 and 3,881,993.
Freake, U.S. Patent No. 3,881,993, discloses a test device for analyzing a sample for microorganisms, said device being adapted to be inoculated with the sample and incubated in a sealable container, the device comprising an absorbent matrix impregnated with a nutrient medium, a reagent, and a water soluble culture-fixing agent capable of forming a ~iscous suspension in an aqueous solution to localize the microorganisms on said matrix.
Kronish, U.S. Patent No. 3,699,003, discloses a pre-paration for the biochemical identification of ~-hemolytic streptococci into serologic groups, e.g., groups A, B, C, D, etc. This preparation comprises a carrier, e.g., a bibulous strip containing a glycerol reagent band, a ; salicin reagent band and an esculin reagent band. In the glycerol and salicin reagent bands there are also pH
indicator systems. The esculin band contains a compound which reacts with esculin breakdown products to produce a color change. These bands are separated from each other by hydrophobic barriers. In use, a quantity of the micro-organism whose serological identification is to be deter-mined is transferred onto each of the three reagent bands.
Notwithstanding these contributions by prior workers in the field, there has been no quick and con~enient means for determinations of deoxyribonuclease production by microbiological samples.
,.......................................... .
, Z.
.
.
~83~8 OBJECTS OF THE INVENTION
It is therefore an object of the present invention to provide an improved test for the detection of deoxyribo-nuclease in biological samples.
It is another object of the invention to provide an improved deoxyribonuclease test in device format.
Yet another object of the invention is to provide a test device for detection of deoxyribonuclease which can be used directly for collecting the biological specimen.
1~ It is therefore a further object o the present invention to provide a test device, having the above-mentioned advantages, comprising an absorbent matrix incorporated with deoxyribonucleic acid, methyl green, and a water-soluble polymer selected from polyvinyl alcohol and carboxymethylcellulose.
Other objects and a fuller understanding of the invention will be had by referring to the following descrip-tion and claims drawn to preferred embodiments thereof, taken in conjunction with the accompanying drawings in which:
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a plan view of a test device according to the invention having deoxyribonuclease nonproducing colonies thereon; and Fig. 2 is a plan view of a test device according to ; the invention having deoxyribonuclease producing colonies thereon with resultant plaque or clear zone formation.
SUMMARY OF THE INVENTION
.
In accordance with the present invention there is provided test means for determining the production of deoxyribonuclease in a microbiological sample. More particularly, a test device is provided for the detection of deoxyribonuclease production by a microbiological 33~8 sample which comprises a carrier matrix and, incorporated therewith, a composition comprising deoxyribonucleic acid, methyl green, and a water-soluble polymer selected from polyvinyl alcohol and carboxymethylcellulose. Incorporation of the deoxyribonuclease detection system into the carrier matrix is accomplished by impregnation of the carrier matrix with an impregnating solution containing the detection system. A range for the polymer concentration in the impregnating solution is advantageously from about ~.5 grams/ deciliter (g/dl) to about 3.5 g/dl, with
The present invention relates generally to the field of microbiological test devices and, more particularly, to - 5 a test device, process for making the device and method of determining the production of deoxyribonuc]ease in a microbiological sample.
BACKGROUND OF THE INVENTION
; The ability of an organism to break down deoxyribo-nucleic acid (DNA) by means of a deoxyribonuclease (DNAase) has been used clinically to differentiate between groups of microorganisms [Rothberg, N.W. et aZ. J. Baot., 90:294-295 fl965~; BZa~evic, D.J. et aZ. Am. J. CZin. PathoZ. 51: 277-279 fl9ff9); Mart~n, W.J. et aZ. Canad. J. MiorobioZ., 13:
15 616-618 (1967~], to aid in determining the potential pathogenicity of staphylococci lWeekman, B.G. et aZ. J.
Baot., 73:7~7-753, (1957)], and to determine the immuno-logical response to group A streptococcal infections [Wannamaker, L.~., In Vhr, J.W., Ed. The Strepto¢ocous, Rheumati¢ Fever, and GZomeruZonephritis, WiZZiam~ B ~iZkins, BaZt~more (1965)].
DNA is a polynucleotide that is composed of a chain of deoxyribonucleotide units. Deoxyribonucleotides are , phosphoric acid esters of nucleosides (a pyrimidine or purine base attached to deoxyribose). The phosphoric ~L
:
,. . . .
, .
., ; .
1~L18328 acid is attached to the deoxyribose ring at either the 3 or 5' position. Examples of deoxyribonucleotides are adenosine-5'-monophosphate (5'-AMP) and guanosine-S'-mono-phosphate (5'-GMP~.
DNAase is an extracellular enzyme that hydrolyzes DNA
to yield oligonucleotides (chains of several deoxyribo-nucleotides). The DNAase of Serratia mar~e6cens yields di-, tri-, and tetranucleotides [NestZe, M. et aZ. J.
BioZ. Chem. 244:5219-5225 (1969) 3. The DNAase of Group A
streptococci produces predominantly products having a chain length of 3 to 10 deoxyribonucleotide units, but also produces mononucleotides [Wannamaker, supra].
DNA has physical and chemical properties different from those of oligonucleotides or mononucleotides, and advantage has been taken of these differences to detect the hydrolysis of DNA by DNAase. Not all of the many methods proposed to determine hydrolysis of DNA are applicable in the clinical laboratory.
An improved medium for detecting DNAase production has been developed [Smith, P.B. et aZ. AppZ. M~crobioZ.
18:991-993 fl969)]. This method utilized a DNAase test medium to which is added methyl green. Methyl green com-bines with DNA to form a green complex at pH 7.5. If the DNA is hydrolyzed, the methyl green is released and be-comes a colorless compound [Kurnick, N.B. et aZ. Arch.
Biochem. 29;41-53 fl950)]. Therefore, the uninoculated medium with DNA is green, if an organism produces DNAase a colorless zone will be seen around the colonies. Gram-positive organisms grow well on this medium.
; 30 Most of the bacterial DNAases studied have been found to require the presence of divalent cations for their activity [Wannamaker, supra]. Media containing peptones will usually contain th~se cations. The pH optima have also been investigated and have been found to range from 5.5 to 8. 5 [Wannamaker, supra; NestZe~ M. et aZ. J. BioZ.
Chem. 244:5213-5218 rl969)]. For clinical purposes, media with a pH of 7.2 have been found to be satisfactory.
.
In another line of investigation, methods have recently been devised in which the standard nutrient medium plate or tube is replaced by nutrient impregnated pads Such devices may comprise a bibulous material such as paper into which the nutrient medium is incorporated in a dried state. These devices are usually employed as test devices by reconstituting the dry media with a sterile fluid, streaking or otherwise contacting the surface of the device with the fluid specimen to be tested, incubating the same under standardized conditions and observing the growth of microorganism locations on the surface. Exemplary of such devices are those disclosed in U.S. Patents Nos.
3,699,003 and 3,881,993.
Freake, U.S. Patent No. 3,881,993, discloses a test device for analyzing a sample for microorganisms, said device being adapted to be inoculated with the sample and incubated in a sealable container, the device comprising an absorbent matrix impregnated with a nutrient medium, a reagent, and a water soluble culture-fixing agent capable of forming a ~iscous suspension in an aqueous solution to localize the microorganisms on said matrix.
Kronish, U.S. Patent No. 3,699,003, discloses a pre-paration for the biochemical identification of ~-hemolytic streptococci into serologic groups, e.g., groups A, B, C, D, etc. This preparation comprises a carrier, e.g., a bibulous strip containing a glycerol reagent band, a ; salicin reagent band and an esculin reagent band. In the glycerol and salicin reagent bands there are also pH
indicator systems. The esculin band contains a compound which reacts with esculin breakdown products to produce a color change. These bands are separated from each other by hydrophobic barriers. In use, a quantity of the micro-organism whose serological identification is to be deter-mined is transferred onto each of the three reagent bands.
Notwithstanding these contributions by prior workers in the field, there has been no quick and con~enient means for determinations of deoxyribonuclease production by microbiological samples.
,.......................................... .
, Z.
.
.
~83~8 OBJECTS OF THE INVENTION
It is therefore an object of the present invention to provide an improved test for the detection of deoxyribo-nuclease in biological samples.
It is another object of the invention to provide an improved deoxyribonuclease test in device format.
Yet another object of the invention is to provide a test device for detection of deoxyribonuclease which can be used directly for collecting the biological specimen.
1~ It is therefore a further object o the present invention to provide a test device, having the above-mentioned advantages, comprising an absorbent matrix incorporated with deoxyribonucleic acid, methyl green, and a water-soluble polymer selected from polyvinyl alcohol and carboxymethylcellulose.
Other objects and a fuller understanding of the invention will be had by referring to the following descrip-tion and claims drawn to preferred embodiments thereof, taken in conjunction with the accompanying drawings in which:
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a plan view of a test device according to the invention having deoxyribonuclease nonproducing colonies thereon; and Fig. 2 is a plan view of a test device according to ; the invention having deoxyribonuclease producing colonies thereon with resultant plaque or clear zone formation.
SUMMARY OF THE INVENTION
.
In accordance with the present invention there is provided test means for determining the production of deoxyribonuclease in a microbiological sample. More particularly, a test device is provided for the detection of deoxyribonuclease production by a microbiological 33~8 sample which comprises a carrier matrix and, incorporated therewith, a composition comprising deoxyribonucleic acid, methyl green, and a water-soluble polymer selected from polyvinyl alcohol and carboxymethylcellulose. Incorporation of the deoxyribonuclease detection system into the carrier matrix is accomplished by impregnation of the carrier matrix with an impregnating solution containing the detection system. A range for the polymer concentration in the impregnating solution is advantageously from about ~.5 grams/ deciliter (g/dl) to about 3.5 g/dl, with
2.0 g/dl to 3.0 g/dl, and especially 2.6 g/dl, being preferred.
Presumptive identification of ~-hemolytic strepto-coccal strains, assumed to be pathogenic and from Lancefield group A, is possible by addition of an appropriate selec-tion of microbial inhibitors in satisfactory concentrations to devices in accordance with the invention. The sub-stantial clinical significance of early and convenient identification of these widespread and invasive pathogens can be readily appreciated.
As an additional aspect of the invention there is provided a process for the determination of deoxyribo-nuclease production by a microbiological sample which comprises contacting a sample with the aforementioned devices, incubating the devices so contacted with the sample, and observing any plaques formed thereon.
The devices described in accordance with the inven-tion are prepared by a process of incorporating an absor-bent matrix with a composition comprising deoxyribonucleic acid, methyl green, and a water-soluble polymer selected from polyvinyl alcohol and carboxymethylcellulose.
It is now possible by using the test device of the present invention to perform in a rapid and convenient manner a determination of clinical specimens, such as body fluids, for the presence of organisms which produce deoxyribonuclease, Such organisms include various aspects of streptococcus, staphylcoccus and organisms in the family Enterobacteriaceae.
.
~1~83~Z~3 DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring to Fig. 1, the test device of the present invention, generally designated as 1, essentially com-prises an absorbent matrix 3, and incorporated therewith, a composition comprising deoxyribonucleic acid, methyl green and a water-soluble polymer selected from polyvinyl alcohol and carboxymethylcellulose. MicrobiaI colonies 2 are interspersed throughout and are visible from the surface of matrix 3. Depicted in this illustration is a reacted device indicating the organism cultured thereon to be a nonproducer of deoxyribonuclease. This is illustrated by noncleared zone 4 which is the unaffected area of the impregnated matrix adjacent to individual colonies 2 growing thereon. Such an appearance of a reacted device would clinically be considered a negative response.
Fig. 2, illustrating a DNAase positive response, shows microbial colonies 2 around which there is a clear zone 5, indicating detection of and reaction with deoxy-ribonuclease by the test composition incorporated into matrix 3. The mechanism of the reaction has in the past generally been considered to be one wherein methyl green combines with polymerized DNA to form a stable, colored complex. If the DNA is hydrolyzed, such as by deoxyribo-nuclease, the methyl green is freed and fades to a color-less compound, thus resulting in the appearance of plaquesidentified on the matrix of the in~ention as clear zone 5.
For the purpose of the present disclosure the term "microorganism" refers to the class of microorganisms including yeast or other fungi, mycoplasma, pleuropneumonia-like organisms, rickettsiae, and chlamydia, but particu-larly to bacteria. The term "colony" refers to the "microorganism" subsequent to culturing. The expression "colony location" or "microbial colony" indicates the site of a colony on matrix 3.
~1~832~
The expression "carrier matrix" or the term "matrix"
refers to bibulous matrices which are insoluble and main-tain their structural integrity when exposed to physio-logic:al or other liquids. Suitable bibulous matrices which can be used include paper, cellulose, wood, synthetic resin, fleeces, non-woven and woven fabrics and the like.
For convenience the matrix can be associated with an insoluble support member, such as one made of polystyrene.
The invention further provides a method for using the test device for determination of deoxyribonuclease pro-duction in microbial test samples The sample is tested by contacting the device with the sample, incubating the device so contacted under generally physlological tempera-ture parameters and observing any clear zone formation on the device after a suitable incubation period. Incubation for the present device is characteristically for a period of from about 12 to about 48 hours, preferably at a temperature generally in the range of 37C.
DNAase test agar used in the following examples were obtained from Difco Laboratories, Detroit, Michigan. Calf thymus DNA used in the following examples was obtained from Research Products Division, Miles Laboratories, Inc., Elkhart, Indiana. Methyl green used in the following examples was obtained from Fisher Scientific Co., Pittsburgh, Pennsylvania and was their M-295 certified biological stain. Standard reagent grade polyvinyl alcohol, carboxy-methylcellulose, and polyvinylpyrrolidone were also obtained from Fisher Scientific Co.
The following examples are merely illustrative and are not to be construed as a limitation of the invention.
One skilled in the art will be able to make such variations, substitutions and changes in the ingredients and para-meters as may seem desirable.
.
EXAMPLE I
Test devices incorporating the deoxyribonucleic acid/
methyl green test for detection of deoxyribonuclease pro-^~ duction were prepared with various additives and compared
Presumptive identification of ~-hemolytic strepto-coccal strains, assumed to be pathogenic and from Lancefield group A, is possible by addition of an appropriate selec-tion of microbial inhibitors in satisfactory concentrations to devices in accordance with the invention. The sub-stantial clinical significance of early and convenient identification of these widespread and invasive pathogens can be readily appreciated.
As an additional aspect of the invention there is provided a process for the determination of deoxyribo-nuclease production by a microbiological sample which comprises contacting a sample with the aforementioned devices, incubating the devices so contacted with the sample, and observing any plaques formed thereon.
The devices described in accordance with the inven-tion are prepared by a process of incorporating an absor-bent matrix with a composition comprising deoxyribonucleic acid, methyl green, and a water-soluble polymer selected from polyvinyl alcohol and carboxymethylcellulose.
It is now possible by using the test device of the present invention to perform in a rapid and convenient manner a determination of clinical specimens, such as body fluids, for the presence of organisms which produce deoxyribonuclease, Such organisms include various aspects of streptococcus, staphylcoccus and organisms in the family Enterobacteriaceae.
.
~1~83~Z~3 DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring to Fig. 1, the test device of the present invention, generally designated as 1, essentially com-prises an absorbent matrix 3, and incorporated therewith, a composition comprising deoxyribonucleic acid, methyl green and a water-soluble polymer selected from polyvinyl alcohol and carboxymethylcellulose. MicrobiaI colonies 2 are interspersed throughout and are visible from the surface of matrix 3. Depicted in this illustration is a reacted device indicating the organism cultured thereon to be a nonproducer of deoxyribonuclease. This is illustrated by noncleared zone 4 which is the unaffected area of the impregnated matrix adjacent to individual colonies 2 growing thereon. Such an appearance of a reacted device would clinically be considered a negative response.
Fig. 2, illustrating a DNAase positive response, shows microbial colonies 2 around which there is a clear zone 5, indicating detection of and reaction with deoxy-ribonuclease by the test composition incorporated into matrix 3. The mechanism of the reaction has in the past generally been considered to be one wherein methyl green combines with polymerized DNA to form a stable, colored complex. If the DNA is hydrolyzed, such as by deoxyribo-nuclease, the methyl green is freed and fades to a color-less compound, thus resulting in the appearance of plaquesidentified on the matrix of the in~ention as clear zone 5.
For the purpose of the present disclosure the term "microorganism" refers to the class of microorganisms including yeast or other fungi, mycoplasma, pleuropneumonia-like organisms, rickettsiae, and chlamydia, but particu-larly to bacteria. The term "colony" refers to the "microorganism" subsequent to culturing. The expression "colony location" or "microbial colony" indicates the site of a colony on matrix 3.
~1~832~
The expression "carrier matrix" or the term "matrix"
refers to bibulous matrices which are insoluble and main-tain their structural integrity when exposed to physio-logic:al or other liquids. Suitable bibulous matrices which can be used include paper, cellulose, wood, synthetic resin, fleeces, non-woven and woven fabrics and the like.
For convenience the matrix can be associated with an insoluble support member, such as one made of polystyrene.
The invention further provides a method for using the test device for determination of deoxyribonuclease pro-duction in microbial test samples The sample is tested by contacting the device with the sample, incubating the device so contacted under generally physlological tempera-ture parameters and observing any clear zone formation on the device after a suitable incubation period. Incubation for the present device is characteristically for a period of from about 12 to about 48 hours, preferably at a temperature generally in the range of 37C.
DNAase test agar used in the following examples were obtained from Difco Laboratories, Detroit, Michigan. Calf thymus DNA used in the following examples was obtained from Research Products Division, Miles Laboratories, Inc., Elkhart, Indiana. Methyl green used in the following examples was obtained from Fisher Scientific Co., Pittsburgh, Pennsylvania and was their M-295 certified biological stain. Standard reagent grade polyvinyl alcohol, carboxy-methylcellulose, and polyvinylpyrrolidone were also obtained from Fisher Scientific Co.
The following examples are merely illustrative and are not to be construed as a limitation of the invention.
One skilled in the art will be able to make such variations, substitutions and changes in the ingredients and para-meters as may seem desirable.
.
EXAMPLE I
Test devices incorporating the deoxyribonucleic acid/
methyl green test for detection of deoxyribonuclease pro-^~ duction were prepared with various additives and compared
3~8 for production of a distinct clear zone surrounding the colony, indicating deoxyribonuclease production.
Solutions according to various formulations were pre-pared for impregnation of paper matrices A base solution was prepared in 300 milliliters (ml) of distilled H20 by addition thereto of 1.50 grams (g) of NaCl, 0 18 g of MgS04, 0 6 g deoxyribonucleic acid (DNA), 0 30 g methyl green and 6.0 g tryptose. The base solution was divided into five aliquots of 50 ml each.
Each of four aliquots of base solution, as prepared above, then received a different additive as follows:
(1) Carboxymethylcellulose (CMC) 1 g ~2) Polyvinyl pyrrolidone ~PVP) 1 g (3) Polyvinyl alcohol (PVA) 1 3 g ~4) Agar 0.5 g (5) Sodium alginate 0 25 g A control was run which contained 50 ml of the base solution, as such, The solutions containing additives were mixed over-night at room temperature. The following day the solu-tions and control were heated to a boil and then auto-claved for 15 minutes at slow exhaust at 121 Centigrade ~C) Sheets of Schleicher ~ Schull (S ~ S) 470 filter paper ~Schleicher ~ Schull Co.~ Keene, NH) were separately impregnated to saturation with each of the solutions and the control, respectively, allowed to dry at room tempera-ture and cut to 2,5 centimeters ~cm) x 2 5 cm to provide test devices. The devices were then placed into petri dishes.
The devices were inoculated with a known culture of ~-hemolytic streptococci species at concentrations of 103/ml, 105/ml and 106/ml organisms. The devices were then incubated for 24 hours at 37C.
The devices prepared with formulations having poly-vinyl alcohol and those having carboxymethylcellulose had distinct "clear" or decolorized areas surrounding colonies of deoxyribonuclease-producing microorganisms at all microorganism concentrations tested. The area surrounding ill83Z8 g the clear zones remained as unchanged shade of green.
Those devices wherein the polymer polyvinylpyrrolidone was used did not, however, provide satisfactory distinct clear zones.
Agar impregnated into the paper only slightly and with difficulty. It tended, rather than impregnating, to form a film layer on the paper. In those devices in which it was possible to impregnate the agar, a diffuse uniform fading of green towards a yellowish color was observed with no distinction around colonies. Although impregna-tion of the paper with formulations having sodium al~inate was not as difficuit as with the agar, the results observed, uniform blanching, were very similar to the agar and, thus, equally unacceptable.
Overall performance indicated PVA to be the best additive for providing distinct clear zones in the test device, with carboxymethylcellulose additionally pro~iding visibly distinguishable clear zones around the colonies.
;
EXAMPLE II
Testing was undertaken to determine the optimum con-centration of PVA for reproducible, distinct zones of clearing, indicating the presence of deoxyribonuclease.
Devices were prepared as in Example I using seven different impregnating solutions respectively containing PVA in the following concentrations: 0.5 grams/deciliter (g/dl), 1.0 g/dl, 1.5 g/dl, 2.0 g/dl, 2.6 g/dl, 3.0 g/dl and 3.5 g/dl.
These device~ were inoculated with the streptococcus organisms from the same culture and in the same concen-trations as used in Example I and incubated as describedtherein.
A distinguishable clear zone around the colony forma-tions was observed at all PVA concentrations tested. The sharpness of demarkation between areas of clearing and the ; 35 green unaffected areas was optimized in the device prepared with the impregnating solution in which PVA was present at the 2.6 g/dl concentration level.
i . .
' ~ ~
:
~118328 Thus, a range of acceptable polymer concentration inthe impre~nating solution of from about 0,5 g/dl to about 3,5 g/dl was shown to be functional in the invention, , EXA~IPLE III
Te t devices incorporating the deoxyribonucleonic aci~s/methyl green test of the present invention are provided ~ith selective chemical inhibitors and anti-biotics so as to provide a de~ice capable of presumptively identifying ~-hemolytic streptococci, Six separate impregnation solutions were prepared in S0 ml of distilled H2O by addition thereto of 0,25 g of NaCl, 0,03 g of ~gSO4, 0,1 g of DNA, 0,05 g of methyl green, l,O g of tryptose, and were formulated to be selective for ~-hemolytic streptococci by addition thereto of one of the following selective chemical inhibitors:
crystal.violet 50 milligrams (mg) (staphylococcus inhibitor) amphotericin B 0,25 mg (mycological inhibitor) sodium colistimethate 2 mg (gram negative inhibitor) naladixic acid 1~5 mg (gram negative inhi~itor) gentamycin 25 micrograms (~g) .
' 25 (staphylococcus inhibitor) `. lithium chloride 0,18 mg (a-hemolytic str~ptococcus) Each impregnation solution was mixed overnight at room temperature. The following day each solution was heated to a boil and then autoclaved for 15 minutes at . slow exhaust at 121C. Separate sheets o~ S ~ S 470 filter paper were respectively impregnated to saturation with the impregnation solutions, allowed to dry at room temperature and cut to 2.5 cm x 2,5 cm to provide devices according to the invention, The devi.ces were then placed into petri dishes, .
': .
, ~118328 One set of devices prepared as above was inoculated with a known culture of ~-hemolytic streptococcus species at concentrations of 103/ml, 105/ml and 106/ml organisms.
Another set of devices prepared as above was inoculated with similar concentrations of DNAase producing staphylo-coccus strains, and a third set of such devices was inoculated with similar concentrations of DNAase producing gram negative organisms. The devices were then incubated for 24 hours at 37C.
The devices were observed after incubation, and clear zone formation was found to be present only in the devices inoculated with the ~-hemolytic streptococcal strains.
Growth was not observed on the other devices and clear zones, indicative of DNAase production, therefore, did not appear.
As can be seen from these results, incorporation of inhibitors into devices in accordance with the invention does provide in addition to a convenient device for deter-mination of DNAase production in strip format, a ~evice which offers presumptive identification of ~-hemolytic streptococcus organisms, such as from clinical samples.
Becuase of the wide spread occurrence of these pathogenic organisms, such a device clearly has distinct advantages for clinical laboratory use.
Although the invention has been described with a certain degree of particularity, it is understood that the present disclosure has been made only by way of example and that numerous changes may be resorted to without departing from the spirit and scope of the invention.
.
~:,
Solutions according to various formulations were pre-pared for impregnation of paper matrices A base solution was prepared in 300 milliliters (ml) of distilled H20 by addition thereto of 1.50 grams (g) of NaCl, 0 18 g of MgS04, 0 6 g deoxyribonucleic acid (DNA), 0 30 g methyl green and 6.0 g tryptose. The base solution was divided into five aliquots of 50 ml each.
Each of four aliquots of base solution, as prepared above, then received a different additive as follows:
(1) Carboxymethylcellulose (CMC) 1 g ~2) Polyvinyl pyrrolidone ~PVP) 1 g (3) Polyvinyl alcohol (PVA) 1 3 g ~4) Agar 0.5 g (5) Sodium alginate 0 25 g A control was run which contained 50 ml of the base solution, as such, The solutions containing additives were mixed over-night at room temperature. The following day the solu-tions and control were heated to a boil and then auto-claved for 15 minutes at slow exhaust at 121 Centigrade ~C) Sheets of Schleicher ~ Schull (S ~ S) 470 filter paper ~Schleicher ~ Schull Co.~ Keene, NH) were separately impregnated to saturation with each of the solutions and the control, respectively, allowed to dry at room tempera-ture and cut to 2,5 centimeters ~cm) x 2 5 cm to provide test devices. The devices were then placed into petri dishes.
The devices were inoculated with a known culture of ~-hemolytic streptococci species at concentrations of 103/ml, 105/ml and 106/ml organisms. The devices were then incubated for 24 hours at 37C.
The devices prepared with formulations having poly-vinyl alcohol and those having carboxymethylcellulose had distinct "clear" or decolorized areas surrounding colonies of deoxyribonuclease-producing microorganisms at all microorganism concentrations tested. The area surrounding ill83Z8 g the clear zones remained as unchanged shade of green.
Those devices wherein the polymer polyvinylpyrrolidone was used did not, however, provide satisfactory distinct clear zones.
Agar impregnated into the paper only slightly and with difficulty. It tended, rather than impregnating, to form a film layer on the paper. In those devices in which it was possible to impregnate the agar, a diffuse uniform fading of green towards a yellowish color was observed with no distinction around colonies. Although impregna-tion of the paper with formulations having sodium al~inate was not as difficuit as with the agar, the results observed, uniform blanching, were very similar to the agar and, thus, equally unacceptable.
Overall performance indicated PVA to be the best additive for providing distinct clear zones in the test device, with carboxymethylcellulose additionally pro~iding visibly distinguishable clear zones around the colonies.
;
EXAMPLE II
Testing was undertaken to determine the optimum con-centration of PVA for reproducible, distinct zones of clearing, indicating the presence of deoxyribonuclease.
Devices were prepared as in Example I using seven different impregnating solutions respectively containing PVA in the following concentrations: 0.5 grams/deciliter (g/dl), 1.0 g/dl, 1.5 g/dl, 2.0 g/dl, 2.6 g/dl, 3.0 g/dl and 3.5 g/dl.
These device~ were inoculated with the streptococcus organisms from the same culture and in the same concen-trations as used in Example I and incubated as describedtherein.
A distinguishable clear zone around the colony forma-tions was observed at all PVA concentrations tested. The sharpness of demarkation between areas of clearing and the ; 35 green unaffected areas was optimized in the device prepared with the impregnating solution in which PVA was present at the 2.6 g/dl concentration level.
i . .
' ~ ~
:
~118328 Thus, a range of acceptable polymer concentration inthe impre~nating solution of from about 0,5 g/dl to about 3,5 g/dl was shown to be functional in the invention, , EXA~IPLE III
Te t devices incorporating the deoxyribonucleonic aci~s/methyl green test of the present invention are provided ~ith selective chemical inhibitors and anti-biotics so as to provide a de~ice capable of presumptively identifying ~-hemolytic streptococci, Six separate impregnation solutions were prepared in S0 ml of distilled H2O by addition thereto of 0,25 g of NaCl, 0,03 g of ~gSO4, 0,1 g of DNA, 0,05 g of methyl green, l,O g of tryptose, and were formulated to be selective for ~-hemolytic streptococci by addition thereto of one of the following selective chemical inhibitors:
crystal.violet 50 milligrams (mg) (staphylococcus inhibitor) amphotericin B 0,25 mg (mycological inhibitor) sodium colistimethate 2 mg (gram negative inhibitor) naladixic acid 1~5 mg (gram negative inhi~itor) gentamycin 25 micrograms (~g) .
' 25 (staphylococcus inhibitor) `. lithium chloride 0,18 mg (a-hemolytic str~ptococcus) Each impregnation solution was mixed overnight at room temperature. The following day each solution was heated to a boil and then autoclaved for 15 minutes at . slow exhaust at 121C. Separate sheets o~ S ~ S 470 filter paper were respectively impregnated to saturation with the impregnation solutions, allowed to dry at room temperature and cut to 2.5 cm x 2,5 cm to provide devices according to the invention, The devi.ces were then placed into petri dishes, .
': .
, ~118328 One set of devices prepared as above was inoculated with a known culture of ~-hemolytic streptococcus species at concentrations of 103/ml, 105/ml and 106/ml organisms.
Another set of devices prepared as above was inoculated with similar concentrations of DNAase producing staphylo-coccus strains, and a third set of such devices was inoculated with similar concentrations of DNAase producing gram negative organisms. The devices were then incubated for 24 hours at 37C.
The devices were observed after incubation, and clear zone formation was found to be present only in the devices inoculated with the ~-hemolytic streptococcal strains.
Growth was not observed on the other devices and clear zones, indicative of DNAase production, therefore, did not appear.
As can be seen from these results, incorporation of inhibitors into devices in accordance with the invention does provide in addition to a convenient device for deter-mination of DNAase production in strip format, a ~evice which offers presumptive identification of ~-hemolytic streptococcus organisms, such as from clinical samples.
Becuase of the wide spread occurrence of these pathogenic organisms, such a device clearly has distinct advantages for clinical laboratory use.
Although the invention has been described with a certain degree of particularity, it is understood that the present disclosure has been made only by way of example and that numerous changes may be resorted to without departing from the spirit and scope of the invention.
.
~:,
Claims (8)
1. A test device for determination of deoxyribo-nuclease production in a microbiological sample, which device comprises a carrier matrix and, incorporated there-with, deoxyribollucleic acid, methyl green and a water-soluble polymer selected from polyvinyl alcohol and carboxymethylcellulose.
2. The test device of Claim 1 wherein the deoxyribo-nucleic acid, methyl green and polymer incorporated with the matrix is the dried residue of a previous impregnation of the matrix with a solution thereof.
3. The test device of Claim 2 wherein the polymer is present in the impregnating solution at a concentration of from about 0.5 g/dl to about 3.5 g/dl
4. The test device of Claim 3 wherein the polymer is present in the impregnating solution at a concentration of about 2.6 g/dl.
5. A process for the determination of deoxyribo-nuclease production in a microbiological sample which comprises contacting the sample with the device of Claim 1, incubating the device so contacted, and observing any clear zones formed thereon.
6. The device of Claim 1 which further comprises inhibitors effective to allow selective growth of .beta.-hemolytic streptococci.
7. The device of Claim 6 wherein said inhibitors include crystal violet, amphotericin B, sodium colisti-methate, naladixic acid, gentamycin or lithium chloride.
8. A process for making the device of Claim 1 which comprises incorporating a carrier matrix with a compo-sition comprising deoxyribonucleic acid, methyl green, and a water-soluble polymer selected from polyvinyl alcohol and carboxymethylcellulose.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90144678A | 1978-05-01 | 1978-05-01 | |
| US901,446 | 1978-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1118328A true CA1118328A (en) | 1982-02-16 |
Family
ID=25414208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000325042A Expired CA1118328A (en) | 1978-05-01 | 1979-04-06 | Device for detecting deoxyribonuclease production |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS54145596A (en) |
| CA (1) | CA1118328A (en) |
| DE (1) | DE2914544A1 (en) |
| FR (1) | FR2425073A1 (en) |
| GB (1) | GB2020017B (en) |
| IT (1) | IT1116469B (en) |
| SE (1) | SE7903639L (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE453020B (en) * | 1983-07-06 | 1988-01-04 | Statens Bakteriologiska Lab | SEROLOGICAL DIAGNOSTICS OF BETA-STRIPTOC TOC INFECTIONS USING MACHINE READING WITH MICROTITION PLATE PHOTOMETER |
| WO2010099068A1 (en) | 2009-02-26 | 2010-09-02 | 3M Innovative Properties Company | Methods and articles for detecting deoxyribonuclease activity |
| CN102356161A (en) | 2009-03-19 | 2012-02-15 | 株式会社钟化 | Nucleic acid detection method, kit, and device |
| EP3596228B1 (en) * | 2017-03-14 | 2022-09-28 | Tubitak | Method for rapid identification of microorganisms producing nuclease enzymes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5188091A (en) * | 1975-01-30 | 1976-08-02 | Toshindanyoogu oyobi sonoseizoho | |
| US3986833A (en) * | 1975-09-08 | 1976-10-19 | Miles Laboratories, Inc. | Test composition, device, and method for the detection of peroxidatively active substances |
-
1979
- 1979-04-06 CA CA000325042A patent/CA1118328A/en not_active Expired
- 1979-04-10 DE DE19792914544 patent/DE2914544A1/en not_active Withdrawn
- 1979-04-12 GB GB7912931A patent/GB2020017B/en not_active Expired
- 1979-04-24 JP JP4986179A patent/JPS54145596A/en active Pending
- 1979-04-25 SE SE7903639A patent/SE7903639L/en not_active Application Discontinuation
- 1979-04-30 IT IT48891/79A patent/IT1116469B/en active
- 1979-05-02 FR FR7911051A patent/FR2425073A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| IT7948891A0 (en) | 1979-04-30 |
| IT1116469B (en) | 1986-02-10 |
| SE7903639L (en) | 1979-11-02 |
| JPS54145596A (en) | 1979-11-13 |
| GB2020017A (en) | 1979-11-07 |
| GB2020017B (en) | 1982-11-17 |
| DE2914544A1 (en) | 1979-11-15 |
| FR2425073A1 (en) | 1979-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bernard et al. | Streptococcal cause of erysipelas and cellulitis in adults: a microbiologic study using a direct immunofluorescence technique | |
| Tharagonnet et al. | The API ZYM system in the identification of Gram-negative anaerobes. | |
| Hébert et al. | 30 years of campylobacters: biochemical characteristics and a biotyping proposal for Campylobacter jejuni | |
| US4259442A (en) | Process of rapid identification of bacteria of the genus Streptococcus | |
| US5627045A (en) | Multi-test format with gel-forming matrix for characterization of microorganisms | |
| CA1288322C (en) | Detection of microbes in a sample | |
| CA1132444A (en) | Negative control media for microbiologic biochemical tests | |
| CA2262923C (en) | Article and method for detection of enterotoxigenic staphylococci | |
| Brun et al. | Micromethod for biochemical identification of coagulase-negative staphylococci | |
| Moncla et al. | Rapid presumptive identification of black-pigmented gram-negative anaerobic bacteria by using 4-methylumbelliferone derivatives | |
| EP0153477B1 (en) | Diagnostic test for streptococcus a | |
| US5047523A (en) | Nucleic acid probe for detection of neisseria gonorrhoea | |
| US5330889A (en) | Process and medium for identification of bacteria of the listeria genus | |
| JP4083980B2 (en) | Culture medium for detecting Listeria pathogenic bacteria and method for identification of the bacteria | |
| US3699003A (en) | Diagnostic preparation for the identification of beta-hemolytic streptococci | |
| Sturm et al. | Characteristics of Haemophilus ducreyi in culture | |
| CA1118328A (en) | Device for detecting deoxyribonuclease production | |
| Hare et al. | The anaerobic cocci: gas formation, fermentation reactions, sensitivity to antibiotics and sulphonamides. Classification | |
| Sng et al. | Characteristics of Haemophilus ducreyi. A study. | |
| Mitchell et al. | Novobiocin resistance and the classification of staphylococci and micrococci | |
| Bennett et al. | Identification of fusobacteria in a routine diagnostic laboratory | |
| Duchaine et al. | Saccharopolyspora rectivirgula from Quebec dairy barns: application of simplified criteria for the identification of an agent responsible for farmer's lung disease | |
| WO1988006189A1 (en) | Test system, test device and method for detecting pathogenic organisms and antibiotic resistance genes in body fluids | |
| US3645853A (en) | Diagnostic composition and method for the detection of nitrate reduction | |
| Stevens et al. | Use of trehalose-mannitol-phosphatase agar to differentiate Staphylococcus epidermidis and Staphylococcus saprophyticus from other coagulase-negative staphylococci |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry | ||
| MKEX | Expiry |
Effective date: 19990216 |